Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0040822 (
tremor
)
18,428
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Male Swiss mice, 20-25 g, were utilized to assess the effects of dermal and oral administration of the pyrethroid insecticide formulations
Pydrin
(30% fenvalerate) and Ambush (25.6% permethrin). Animals were subjected to a conditioned taste aversion procedure using a normally preferred 0.3% saccharin solution. Subjects were allowed 30 min access to a drinking syringe containing the saccharin solution, followed immediately by the administration of the pyrethroid or control solution.
Pydrin
(0.3, 3.0, or 30 mg/kg orally; 60, 600, or 1800 mg/kg dermally) and Ambush (0.5, 5.0, or 50 mg/kg orally; 30, or 300 mg/kg dermally) produced significant (p less than 0.05) reductions in the percent saccharin consumed. Total fluid intake, however, was not significantly altered by any of the treatments. The effect of the insecticides on both grouped and individual activity was also assessed in 20-25 g male Swiss mice. Activity measurements were taken over the 4-hr time period immediately following the administration of the pyrethroid or control solution.
Pydrin
(30 mg/kg orally; 600 and 1800 mg/kg dermally) and Ambush (50 mg/kg orally; 300 mg/kg dermally) significantly (p less than 0.05) increased activity in both grouped and individually tested mice. When subjects were individually tested, significant increases were seen in non-ambulatory, but not in ambulatory activity. The results of this work indicate that administration of the commercially available preparations of
Pydrin
and Ambush in mice at doses that do not induce the
tremor
and choreoathetosis-salivation syndromes usually associated with pyrethroid insecticides may result in behavioral changes.
...
PMID:Behavioral effects of pydrin and ambush in male mice. 339 18
Intraperitoneal administration of fenvalerate, a synthetic pyrethroid, in male rats for 45 days in doses of 100 and 200 mg/kg body weight/day induced hyperexcitability, tremors and paralysis.
Tremors
were observed after 7 days and gradually reached maxima on 45th day. The symptoms were more marked in rats treated with 200 mg/kg body weight/day.
Fenvalerate
provoked significant elevation of circulatory thyroid hormones, namely tri-iodothyronine (T3) and thyroxine (T4). A significant increase in total calcium as well as protein-bound calcium in whole brain and hypothalamus were recorded. The elevation of circulatory thyroid hormones as well as the active calcium pool could be together responsible for impairment of motor activity by altering various neuronal processes.
...
PMID:Fenvalerate-induced alterations in circulatory thyroid hormones and calcium stores in rat brain. 895 8